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Abstract: The paper is a review of the literature on the ethnobotanical, chemical 
and pharmacological aspects of the species Cissampelos sympodialis Eichler, 
Menispermaceae, in order to assess its potential for the treatment of asthma. 
The aqueous infusion from the leaves of this Brazilian plant is used in the 
traditional medicine for the treatment of respiratory conditions, including 
colds, bronchitis and asthma. A multidisciplinary approach has led to the 
elucidation of the main chemical biomarkers and of the mechanism of action 
of the extract and its isolated constituents in animal models of inflammation 
and asthma. A comprehensive review of the literature on the species and its 
related chemical constituents was conducted using Pubmed, Web of Sciences, 
Lilacs, SciFinder, as well as conference proceedings. Retrieved literature data 
demonstrates that the aqueous fraction of the ethanolic extract from the leaves 
exerts an immunomodulatory activity in different animal models of asthma. 
This include an increase in the levels of anti-inflammatory cytokines, a decrease 
in the production of antigen-specific immunoglobulin, a decrease in mucus 
production and deposition in the airways, and a direct bronchodilator activity. 
These preclinical results clearly demonstrate the potential of this species for 
the treatment of asthma and points to the need for well-designed clinical trials 
to finally validate the traditional use of this herbal medicine.
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Introduction
 Asthma is a chronic infl ammatory condition of 
the airways characterized by hyper-responsiveness and 
different degrees of airfl ow obstruction (Holgate, 2012). 
Current therapeutic approaches to asthma have arisen from 
the realization that it is mainly an infl ammatory disease 
associated with immune system imbalance resulting in 
the production of proinfl ammatory cytokines, deposition 
of mucus, smooth muscle proliferation resulting in 
airway remodeling, and bronchospasm. The current 
treatment for mild to severe asthma relies on the use 
of inhaled corticosteroids to prevent acute episodes of 
asthma (Society, 2012). While effective and with fewer 
side effects than treatment with systemic corticosteroids, 
inhaled corticosteroids are not devoid of systemic effects 
and associated side-effects, especially when used at higher 
doses (Petrisko et al., 2008). Thus, the search for alternative 
treatments is a continuing effort that together with a better 
understanding of the physiopathology of the disease has 
led to the introduction of new therapy approaches for 
asthma, such as leukotrine receptor antagonists (LTRA).
 Different classes of naturally-occurring 
substances have proved useful for the treatment of 
asthma, including theophylline, a phosphodiestarase 
inhibitor that is still used therapeutically. Other examples 
include fl avonoids (Yang et al., 2012), coumarins 
(Xiong et al., 2012), anthraquinones (Chu et al., 2012), 
triterpenes (Lee et al., 2012), triterpene saponins (Yuan 
et al., 2011), naphtoquinones (Lee et al., 2010), amongst 
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others. However, most studies on the effects of plants and 
associated isolated compounds on asthma have limitations 
regarding focus on a single particular asthma model, 
use of non-standardized extracts, lack of knowledge 
on the active constituents or lack of knowledge on the 
mechanism of action involved. There is also an urgent 
need for well controlled clinical trials.
 The species Cissampelos sympodialis Eichler, 
Menispermaceae, is endemic to Brazil and is distributed 
mainly within the northeastern states of Paraíba, Ceará, 
Alagoas, and Bahia. It is popularly known as “milona”, 
“jarrinha”, “orelha-de-onça” and “abuteira”. Despite its 
occurrence in many Brazilian states, there are only scarce 
reports of the use of this plant species for medicinal 
purposes. In Paraiba, the aqueous infusion of the plant 
leaves is used for treatment of several different respiratory 
diseases such as asthma and bronchitis, as well as other 
infl ammatory diseases such as arthritis and rheumatic 
disorders (Agra et al., 2007; Barbosa Filho et al., 1997).
 This paper reviewed the literature on the 
ethnobotanical, chemical and pharmacological aspects of 
the species C. sympodialis in order to assess the potential 
of the plant and its constituents for the treatment of 
asthma. The review was based on the following databases: 
ISI Web of Science, NLM Medline (Pubmed), Embase, 
Lilacs, as well as conference proceedings in the area of 
natural products. The following search terms were used: 
“Cissampelos sympodialis”, “milona”, “warifteine”, 
“methylwarifteine”, “milonine”, “roraimine”. In addition, 
a search using Scifi nder® on all substances reported 
to have been isolated from C. sympodialis was also 
conducted. All searches carried no date or other limits.
 There is a wealth of preclinical results pointing 
to a promising role of the aqueous fraction of the ethanol 
extract of C. sympodialis leaves in the treatment of 
asthma. These results are based on different animal 
models of asthma, and different modes of administration 
of the aqueous fraction of the ethanol extract, including 
the intraperitonial, oral and most importantly, the inhaled 
route. Taken together the results pave the way for well-
designed controlled clinical trials to establish if these 
preclinical results can be translated to human use in the 
treatment of asthma.
Botanical and agronomical aspects
 The Menispermaceae family consists of seventy 
genera and around 420 species. Most species in this 
family are climbing plants and many of them are used 
in the folk medicine. They are distributed on tropical 
and sub-tropical regions of all continents and can be 
found in different types of soil, vegetation and habitat 
(Jahan et al., 2010). The genus Cissampelos comprises 
nineteen species, nine of which occur in Brazil (Rhodes, 
1975; Jacques & Bertolino, 2008; Stevens, 2012). In 
the northeastern Brazilian state of Paraíba three species 
Figure 1. Cissampelos sympodialis Eichler: A. Adult plant; B. Detail of deltoids leaves and the ripened fruits (red coloured).
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were catalogued: C. sympodialis, C. glaberrima and C. 
ovalifolia, which share many morphoanatomical features, 
but can be distinguished by careful examination of their 
leaves and by their habitat (Barbosa Filho et al., 1997).
 Cissampelos sympodialis is found from the state 
of Ceará (northeastern Brazil) to the north of Minas Gerais 
(southeast). It is distinguished mainly by the deltoid 
shape of its glabrous leaves. Another noteworthy feature 
is the presence of 3-6 pistillate flowers per fascicle in 
inflorescence. Its fruit is of drupaceous type, obovate, and 
from red to orange when ripe (Figure 1) (Eichler, 1864, 
Rhodes, 1975; Barbosa Filho et al., 1997). Amongst the 
most important microscopic anatomical characters for the 
differentiation of Cissampelos species are the morphology 
of the leaf epidermal cells. C. sympodialis has epidermal 
cells with anticlinal walls on the adaxial side and wavy 
to irregularly sinuous-wave cells in the abaxial leaf side. 
This, together with the absence of secretory bags serve 
as diagnostic characters for the species (Porto et al., 
2008; 2011). Seed germination occurs in 18 to 25 days, 
the onset of flowering at around 150 days after planting 
and the period between flowering and ripening of fruits is 
approximately 26 days (Fonseca & Figueirêdo, 1999).
 Chemistry and bioactive markers
 Scientific recognition of many plant species have 
revealed the presence of phytochemical constituents with 
important pharmacological activities (Jahan et al., 2010). 
Menispermaceae species have extensive use in traditional 
medicine, with twenty-nine of its genera reported to find 
use for medicinal purposes to treat a variety of diseases all 
over the world (Barbosa-Filho et al., 2000; De Wet & Van 
Wyk, 2008). 
 The species from the family Menispermaceae 
are marked by the presence of many alkaloid types, 
especially bisbenzylisoquinoline alkaloids, which 
are derived from benzyltetrahydroisoquinoline 
skeleton. Bisbenzylisoquinolinic (BBI) alkaloids are 
reported to have many pharmacological activities, like 
acetylcholinesterase (AChE) inhibitors (Ingkaninan et 
al., 2006; Cometa et al., 2012); antibacterial, antifungal, 
antiplasmodial, and cytotoxic activities (Lohombo-
Ekomba et al., 2004); antinociceptive and anti-arthritic 
activity (roots of Cissampelos pareira) (Amresh et al., 
2007); anthelmintic activity (Ayers et al., 2007). Some 
plant families that are rich in BBI alkaloids and have 
shown some of the abovementioned activities include 
species from the families Berberidaceae, Monimiaceae, 
Ranunculaceae and Lauraceae (Sun et al., 2000). 
 The number of substances that have been 
isolated over the years from Menispermaceae species is 
impressive, with 1522 alkaloids isolated between 1970-
1997. These alkaloids belong to 23 different structural 
groups, with bisbenzylisoquinoline alkaloids being 
the most represented group, followed by aporfinic and 
protoberberinic alkaloids (Barbosa-Filho et al., 2000).
 The species of Cissampelos that occur in Paraíba 
are characterized by the presence of isoquinoline-
derived alkaloids (Oliveira-Junior et al., 2011). A total 
of 53 different alkaloids belonging to seven different 
skeletons are reported in the literature (Barbosa Filho et 
al., 1997; 2000). The chemical studies with the species 
C. sympodialis has led to the isolation and structural 
elucidation of the following alkaloids: warifteine (Cortes 
et al., 1995), methylwarifteine (Barbosa Filho et al., 1997), 
laurifoline, sympodialine (Alencar, 1994), milonine 
(Defreitas et al., 1995), roraimine, liriodenine (de Lira 
et al., 2002), desmethylroraimine (Marinho, 2011) (Chart 
1). Methylwarifteine has been shown to be an analog 
of an alkaloid isolated from Cissampelos pareira Linn. 
cissampereine (Borkakoti & Palmer, 1978).
 The main bioactive substance present in C. 
sympodialis leaf ethanol extract identified so far is 
warifteine, an amorphous yellow BBI alkaloid, melting 
point 256 °C with decomposition (Aragao et al., 2001), 
insoluble in polar solvents, but a water soluble salt 
in acidic conditions (Cerqueira-Lima et al., 2010), 
that occurs at a concentration of approximately 1% in 
weight in the concentrated ethanol leaf extract (Thomas 
et al., 1997b). This substance was first isolated from 
Cissampelos ovalifolia (Gorinsky et al., 1972; Mukherjee 
& Keifer, 2003). The former studies with C. ovalifolia 
were motivated by its use by South American indians in the 
preparation of curare. Non-depolarizing neuromuscular 
blocking activity of warifteine with potency similar to 
that of tubocurarine and local anesthetic activity was 
previously described (Gorinsky et al., 1972). Together 
with warifteine, the other bioactive alkaloids isolated 
from the ethanol leaf extract of C. sympodialis include 
methylwarifteine, and milonine, a morphinandienone-
type alkaloid. These alkaloids are implicated in the 
pharmacological actions described for the extract of the 
plant (see the section on “pre-clinical pharmacology” 
below). 
 A recent study, aimed at the standardization of 
the leaf ethanol extract, reported the development of a 
high performance liquid chromatography method to 
simultaneously quantify the three main bioactive alkaloid 
markers in the extract of C. sympodialis (Marinho et 
al., 2012). The developed method was used to study 
the concentration of warifteine, methylwarifteine and 
milonine during the vegetative cycle of the plant and 
the study reported that the concentration of the alkaloids 
reach a minimum during ripening of the fruits. Since both 
warifteine and methylwarifteine were found in the extract 
of the ripened fruits, it seems that the biosynthesis of the 
alkaloids is diverted from the leaves to the fruits during 
ripening.
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Chart 1. Alkaloids isolated from Cissampelos sympodialis Eichler and related pharmacological activities.
Structure/Compound name Pharmacological activity Part of the plant
N(CH3)2
H3CO
HO
H3CO
OH
laurifoline (Alencar, 1994)
Laurifoline considerably inhibited the avian myeloblastosis 
virus reverse transcriptase, and could be a promising 
antiretroviral agent (Jucá, 1998)
Leaves of C. sympodialis. Also 
isolated from Hypserpa nitida, 
Menispermaceae (Cheng et al., 
2007)
N
CH3
HO
O
N
O
H3CO OH
H
CH3O
OCH3
 
simpodialine-β-N-oxide (Alencar, 1994)
Not reported Roots of C. sympodialis
H3CO
HO
H3CO
O
NCH3H
 
milonine (Defreitas et al., 1995)
-Hypotensive and vasorelaxant effects in normotensive rats 
(Cavalcante et al., 2011). 
-Spasmolitic effect (DeFreitas et al., 1996; Melo et al., 2003)  
-Cytotoxic effects in culture hepatocytes and V79 fibroblasts 
(Melo et al., 2003) 
-May contribute to the anti-allergic effects of C. sympodialis 
extract (Bezerra-Santos et al., 2012a)
Leaves of C. sympodialis. 
Also isolated from Dehaasia 
longipedicellaata (Mukhtar et 
al., 2004)
N
CH3
HO
O
N
O
H3CO OCH3
H
OCH3
 
methylwarifteine (Barbosa Filho et al., 1997)
It has shown significant and reproducible inhibitory activity 
against human carcinoma cells of the nasopharynx in cell 
culture (Kupchan et al., 1965)
Root, leaves of C. sympodialis. 
Also isolated from C. ovalifolia 
(Borkakoti & Palmer, 
1978); Aristolochia ridicula, 
Aristolochiaceae (Machado & 
Lopes, 2010)
N
CH3
HO
O
N
O
H3CO OH
H
OCH3
warifteinne (Barbosa Filho et al., 1997)
-Spasmolytic activity, relaxant effect in both vascular and 
nonvascular smooth muscle tissues (Cortes et al., 1995; 
DeFreitas et al., 1996; Melo et al., 2003)  
-Cytotoxicity in fibroblast cell line (V79); inhibition of the 
mast cell degranulation and histamine release (Melo et al., 
2003). 
-Antialergic action (Bezerra-Santos et al., 2006) 
-Selectively inhibits cAMP phosphodiesterase activity 
(Thomas et al., 1997) 
Induces muscle relaxation by inhibiting Ca++ channels 
and modifying the intracellular Ca++ stores sensitive to 
noradrenaline (Cortes et al., 1995; DeFreitas, 1994).
Roots, leaves of C. 
sympodialis. Also isolated from 
C. ovalifolia (Borkakoti & 
Palmer, 1978)
N
O
O
O
 
liriodenine (de Lira et al., 2002)
-Extensive pharmacological activities, such as antitumor, 
antibacterial, antifungal and trypanocidal activities, as well 
as anti-Alzheimer's disease (Liu et al., 2011) 
-Larvicidal activity against the third-instar of Aedes aegypti 
larvae (Feitosa, 2009)
Leaves of C. sympodialis. 
Also isolated from Annona 
crassiflora, Annonaceae 
(Gonçalves et al., 2009), 
Annona foetida, Annonaceae, 
(Costa et al., 2011), 
Zanthoxylum nitidum, Rutaceae 
(Chen et al., 2012), Rollinia 
leptopetala, Annonaceae 
(Feitosa, 2009)
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Pre-clinical pharmacology
Toxicological Studies
 There are few studies assessing the toxicological 
effects of C. simpodialis, however, research points out to 
the safety of using the aqueous fraction of the ethanol 
extract of the leaves (AFL), which is the fraction used in 
all pharmacological tests with the species.
 Acute administration of the ethanol leaf extract 
at a dose of 5g/kg orally did not cause mortality in 
mice, rats or dogs. However, changes were observed in 
liver due to increased activity of the enzyme aspartate 
aminotransferase (AST) and alanine aminotransferase 
(ALT) in rats and γ-glutamyl transferase (GGT) and 
alkaline phosphatase in dogs. These effects were transient 
and reversed after discontinuation of treatment (Diniz, 
2000). 
 A subacute study conducted in dogs using an oral 
dose five times greater than that used in folk medicine 
(45 mg/kg/dia), demonstrated that AFL did not induce 
any significant effect on hematological and biochemical 
parameters. Thus, it was concluded that AFL is devoid of 
toxic effect, although these results must be confirmed by 
histological studies, evaluation of its effect on fertility 
and pregnancy and adverse effects such as teratogenicity 
and carcinogenicity (Diniz et al., 2002).
 A subsequent study has investigated the safety 
of the AFL of C. sympodialis at therapeutic oral doses 
(9.0, 45.0 and 225.0 mg/kg) during the entire period 
of pregnancy in female rats. The offspring showed no 
malformations and no interference on the weight gain 
of the developing litter was observed, which reflects the 
absence of adverse effects during pregnancy (Maior et 
al., 2003).
 In a separate study, an anorexic effect of AFL 
was observed in rats. Thus, chronic administration of AFL 
in female rats, at doses of 45 and 225 mg/kg, produced a 
reduction of food consumption and a loss of body weight 
similar to the effects observed by metamphetamine and 
mazindol, in a sex-dependent manner, in addition to 
observed behavioral changes such as significant decrease 
(p<0.05) on the locomotion frequency, rearing, grooming 
and defecation. The observed anorexic effect of AFL 
was attributed to milonine, a morphinadienone aklaloid 
present in the leaves, but no in the roots of C. sympodialis 
(Almeida et al., 2005).
 A preliminary clinical toxicology testing with 
an aqueous infusion of the leaves of C. sympodialis, 
evaluated the stimulating effect of the species on the 
neuromotor Hoffmann’s reflex in the soleus muscle of 
adult volunteers. One group received the infusion in a 
concentration of 1% of the dried leaves of milona and 
another group a placebo infusion. Thus, intake of the 
leaf tea a concentration of 10 mg/mL, did not affect the 
Hoffmann reflex, suggesting that neuromotor activity is 
not affected (Souza et al., 2000). However, independent, 
blinded evaluation of the groups is not reported in the 
study.
 A preliminary phase I clinical trial of a syrup 
of C. sympodialis leaves was conducted using 35 
healthy volunteers (21 males and 14 females), who were 
administered 10 mL of  syrup at 5.4% (weight/volume of 
crude leaf ethanol extract) for 30 days and accompanied 
by clinical examination, electrocardiogram (ECG) and 
laboratory tests. The syrup proved to be well tolerated 
and of low toxicity, but lacked proper standardization 
and quality control (Amaral et al., 2002; Gambarra et al., 
2002).
 The cytotoxicity of the isolated alkaloids 
warifteine and milonine was evaluated in primary 
cultures of rat hepatocytes and fibroblasts from chinese 
hamster lung (V79 cells). In the viability study of 
hepatocytes, warifteine showed toxicity (IC50 around 
10 mM) similar to the cytotoxic effects determined in 
the V79 cells. However, milonine was less toxic than 
warifteine in hepatocytes and V79 cells, also showing 
similar cytotoxic effects in both cell cultures analyzed. 
Cimetidine (a cytochrome P450 inhibitor) was unable to 
protect the cells from the action of warifteine or milonine 
at the concentration used, which means that toxic effects 
induced by these compounds are probably independent of 
the cytochrome P450 system (Melo et al., 2003).
 Although the results demonstrated a cytotoxic 
effect for the alkaloids isolated from C. sympodialis, this 
toxicity is not reproduced during the administration of 
AFL in the acute and subacute studies in rats and dogs 
previously mentioned. It is worth mentioning that the 
alkaloids milonine, warifteine and methylwariteine are 
found in small amounts in the leaf ethanolic extract, with 
warifteine occuring at 1% (in weight) in the concentrated 
extract. However, the concentration of these alkaloids 
N
CH3
HO
O
N
O
H3CO OCH3
H
OCH3
O
 
roraimine (de Lira et al., 2002)
May contribute to the anti-allergic effects of C. sympodialis 
extract (Bezerra-Santos et al., 2012b)
Roots of C. sympodialis
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in the aqueous fraction of the ethanol extract (AFL) is 
anticipated to be much lower due to their small aqueous 
solubility. Despite indications of low toxicity, definite 
chronic toxicological studies are lacking and should be 
conducted with the AFL at the therapeutic dose intended 
for human use.
Activity on smooth muscle
 One of the earliest reported pharmacological 
activities of the plant is its action on the tone of smooth 
muscle. The direct activity of AFL and warifteine on 
smooth muscle tonus is thought to contribute with the 
activity of the plant seen on experimental models of 
asthma. Thus, the extract preparation of C. sympodialis 
is able to relax several smooth muscle tissues with 
equipotent activity between aqueous fraction of the 
ethanolic extract of the root (AFR) and leaf (AFL) 
(DeFreitas, 1994). The AFL also has a relaxing effect in 
tracheal smooth muscle (Thomas et al., 1997b), reducing 
in a dose dependent manner the spontaneous tone and 
relaxing tracheal strips precontracted with capsaicin, 
carbachol and arachidonic acid. The aqueous fraction 
of the ethanol leaf extract on trachea is equipotent to 
aminophylline and seems to involve the intracellular 
increase in the concentration of cyclic adenosine 
monophosphate (cAMP), as observed in guinea-pig 
alveolar macrophages (Thomas et al., 1995). AFL was 
also able to inhibit both the histamine bronchospasm 
response to ovalbumim (OVA) in sensitized guinea pigs 
and the activity of cyclic nucleotide phosphodiesterase 
(PDE) enzymes IV and V in cultured tracheal muscle 
(Thomas et al., 1997a). Even though it was reported that 
warifteine has local anaesthetic activity (Gorinsky et al., 
1972) and generally anaesthetic substances contribute 
to smooth muscle relaxation, this is not the case with 
warifteine. The effect of warifteine, the plant major 
alkaloid on smooth muscle has been investigated in 
detail. Warifteine has smooth muscle relaxing properties, 
acting both in vascular and nonvascular tissues (Cortes et 
al., 1995; DeFreitas et al., 1996). The mechanism of the 
spasmolytic effects of warifteine involves the inhibition 
of calcium channels and interference with noradrenalin 
sensitive intracellular calcium stores. The alkaloid is able 
to inhibit voltage-dependent calcium channels in KCl-
induced contractions; also, it inhibits receptor-operated 
calcium channels, and calcium release from intracellular 
stores such as those sensitive to IP3 and rhyanodine, 
showing that there are many ways that warifteine relaxes 
smooth muscle through calcium-regulatory processes 
(DeFreitas et al., 1996). Another alkaloid from C. 
sympodialis, milonine, has a vasorelaxant action partly 
mediated by endothelium, activation of nitric oxide-
cGMP pathway and the opening of K+ channels, being 
able to lower arterial pressure in normotensive rats 
(Cavalcante et al., 2011). It was shown that AFL induces 
contraction in rat aortic rings modulated by nitric oxide 
and cyclooxigenase-derived relaxing factor, which may 
contribute to the mild hypertensive effect of the plant in 
normotensive rats, an effect that points to careful usage 
of the extract in hypertensive individuals (Freitas et al., 
2000).
Anti-inflammatory activity
 Since asthma can be considered a chronic 
inflammatory condition, it is important for its treatment 
that drugs act to control the release and actions of 
inflammatory mediators. It is widely recognized that 
there is no experimental model of inflammation that 
covers all its aspects. The usual methods to determining 
whether compounds have anti-inflammatory activity are 
through tests with animal and biochemical models of 
inflammation (Lewis, 1989; Barbosa-Filho et al., 2006).
 The aqueous fraction of the ethanolic extract 
obtained from the leaves (AFL) of Cissampelos 
sympodialis was evaluated for anti-inflammatory activity 
and results showed that in mice, the AFL (100 mg/kg, 
i.p.) inhibited both the 12-O-tetradecanoylphorbol 13-
acetate and capsaicin- induced ear edema by 58 and 37%, 
respectively. The effective dose of AFL to inhibit the 
carrageenan-induced rat paw edema was 50 mg/kg (24%). 
Preliminary results of experiments on cell migration 
showed that the administration (by subcutaneous route) 
of AFL at 100 and 200 mg/kg in rats inhibited the 
carrageenan-induced neutrophil migration measurement 
by 53 and 50%, respectively after the administration of 
the irritant (Barbosa-Filho et al., 2006).
 To broaden the knowledge on the suitability to 
use C. sympodialis for the treatment of allergic diseases 
the effect of the intraperitoneal treatment with AFL in 
ovalbumin-sensitized BALB/c mice was evaluated. The 
immunological aspects investigated were the anaphylactic 
shock reaction induced by ovalbumin or compound 48/80, 
immunoglobulin E production and cell proliferative 
response. Data showed that sub-acute AFL-treatment 
inhibited the animal rate mortality by OVA challenge 
by 50% (200 mg/kg i.p.) and 30% (400 mg/kg, i.p.), 
suggesting that the intraperitoneal AFL administration 
may have an anti-allergic activity through the decrease of 
IgE production. However AFL-treatment did not inhibit 
the anaphylactic shock reaction induced by compound 
48/80 injection, although the mechanism involved in this 
anaphylactic response is not receptor dependent unlike 
IgE-mediated responses (Bezerra-Santos et al., 2005).
 Another species of Menispermaceae, Abuta 
grandifolia, also showed anti-inflammatory activity on 
the carrageenan-induced paw edema model in rats when 
administered intraperitoneally (Lima et al., 2011).
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Immunomodulatory activity
 Immunomodulation using medicinal plants 
can be an alternative to conventional chemotherapy for 
several diseases, including asthma. The immune response 
requires multiple interactions between cell types in order 
to maintain immune homeostasis and many plant derived 
materials have been demonstrated to be stimulators of the 
immune system (Kumar et al., 2012). 
 Neutrophil recruitment to the inflammatory 
focus is a complex process, highly orchestrated by a 
huge array of inflammatory mediators (Hebeda et al., 
2011). Since neutrophils are key cells in allergy and 
inflammation by releasing newly synthesized and pre-
stored proinflammatory mediators, the role of this cell 
type in the effects of AFL was investigated. The aqueous 
fraction of ethanol leaf extract (30-100 mg/mL) was 
able to inhibit degranulation of cells stimulated by 
formyl-Met.Phe.Pro, increase the levels of cAMP, and 
the activity of cAMP-dependent protein kinase A. The 
inhibition of neutrophil degranulation was greater when 
the cells were pretreated with the phosphodiesterase 
(PDE) inhibitor isobutyl methyl xanthine (IBMX) and 
AFL had a similar effect on inhibition of lysozyme release 
by dibutyryl cAMP (db-cAMP) and myeloperoxidase 
release by PGE2, suggesting that the fraction may act by 
elevating intracellular cAMP levels (Thomas et al., 1999). 
Considering the deleterious action of neutrophils to the 
inflamed tissue in case of non-controlled inflammation, 
blockade of that step is an important therapeutic strategy 
(Pease & Sabroe, 2002; Yusuf-Makagiansa et al., 2002).
 Allergic asthma is associated particularly with 
a polarized type-2 response modulated by IL-4 and IL-5, 
and involving up-regulation of IL-10. The up-regulation 
of IL-10 production during allergic responses may serve 
to control tissue inflammation that is characterized 
by leukocytic infiltration. Cytokines, a large group of 
soluble extracellular proteins or glycoproteins, are key 
intercellular regulators and mobilizers and they are now 
seen to be crucial to innate and adaptive inflammatory 
responses (Oppenheim, 2001; Spelman et al., 2006). 
Thus, a study tested the hypothesis that the therapeutic 
effect of the AFL obtained from C. sympodialis may be 
related to a differential control in cytokine secretion. 
The effect of the aqueous fraction of ethanol leaf extract 
on cytokine production induced by Con-A in BALB/c 
spleen cells was investigated, and the results showed that 
the extract (6.25 to 50 μg/mL) inhibits the proliferative 
responses of murine spleen cells to Concanavalin-A 
without inhibiting the production of cytokines by the 
cells. Additionaly, AFL induces an increase in IL-4 and 
IL-10 levels, both of these cytokines being potent anti-
inflammatory molecules that act by inhibiting synthesis 
of pro-inflammatory cytokines. The study also found 
a small decrease in IL-2 secretion despite the major 
inhibition of cellular proliferation and it is suggested that 
increased IL-10 production downregulates IFN-gamma 
secretion and T cell proliferative responses (Piuvezam 
et al., 1999). In addition to the inhibitory action of IL-
10 on most in vitro studies, other studies suggest that 
recombinant IL-10 might prove useful for the prevention 
and treatment of certain inflammatory processes in vivo 
(Gérard et al., 1993; Howard et al., 1993; Donckier et al., 
1994).
 Besides its effect on macrophage function, 
IL-10 is also an important regulator of immune and 
inflammatory function (Abrahamsohn, 1998) and a 
study investigated the effect of AFL from C. sympodialis 
on macrophage function, an additional aspect of the 
inflammatory response. This was done by studying the 
effects of AFL on macrophages after in vitro infection 
with the protozoan Trypanosoma cruzi DM28c clone. The 
outcome of T. cruzi interaction with macrophages may 
depend on the activation state of the macrophage (Golden 
& Tarleton, 1991). The authors observed that AFL (13 
to 100 μg/mL) increased T. cruzi growth by a 75% 
reduction in nitric oxide production and this inhibition 
could be mediated by the stimulation of macrophage 
interleukin-10 (IL-10) secretion. These results indicate 
that one of the mechanisms by which AFL exerts an anti-
inflammatory effect could be related to a decrease in 
macrophage activity (Alexandre-Moreira et al., 2003a).
 To better characterize the effect of C. 
sympodialis extract on physiological processes relevant 
to the pathophysiology of asthma, it was important to 
obtain more detailed knowledge about the modulation of 
immunological function by the extract. It was observed 
that AFL inhibited the in vitro proliferative response of 
resting B cells induced by lipopolysaccharide LPS with 
an IC50 of 17.2 μg/mL, anti-delta-dextran (IC50 13.9 μg/
mL) and anti-IgM (IC50 24.3 μg/mL) but did not affect 
the anti-MHC class II antibody-stimulated proliferative 
response of B cell blasts obtained by stimulation with 
IL-4 and anti-IgM. Incubation with the aqueous fraction 
of ethanol extract used at 50 μg/mL induced an increase 
in intracellular cAMP levels and IgM secretion by resting 
B cells and polyclonally activated B cells was inhibited. 
It was concluded that even activated cells could be 
inhibited by AFL, depending on the nature of the B cell 
activator used. This inhibitory effect on B cells could be 
an additional mechanism for the anti-inflammatory effect 
of this extract (Alexandre-Moreira et al., 2003b).
 The action of the isolated alkaloid warifteine on 
B lymphocyte function was also studied and the results 
suggested that it is a potent inhibitor of B cell response 
both in vitro and in vivo and that this effect may be 
due to the induction of increased intracellular cAMP 
levels, suggesting that this substance may be useful as a 
modulator of B cell function (Rocha et al., 2010).
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Activity on animal models of asthma 
 Animal models of asthma have been used for 
over 100 years (Karol, 1994) and there are numerous 
examples of processes and mediators that have been 
identified in animal models and are now known to be 
critical in the development and progression of disease in 
humans (Zosky & Sly, 2007).
 A study in 1995 was the first to suggest a 
pharmacological basis for the use of the plant in asthma 
demonstrating that the aqueous fraction of the ethanol 
extract of the root of C. sympodialis reduced the 
spontaneous tone of trachea, inhibited the contractions 
induced by submaximal concentrations of carbachol, 
histamine, prostaglandin, and substance P in guinea-pig 
tracheal preparations and also increased the intracellular 
levels of cyclic adenosine monophosphate in guinea-pig 
bronchoalveolar leucocytes (Thomas et al., 1995).
 Based on the spasmolitic activity of the root and 
leaf extract of C. sympodialis and as the leaves are an easily 
renewable source on which no studies have been reported, 
the bronchodilator activity of the aqueous fraction of the 
ethanolic extract of the leaves (AFL) was investigated in 
the guinea-pig through an in vivo study investigating its 
ability to protect guinea-pigs against convulsions when 
exposed to aerosols of histamine in normal animals, or of 
ovalbumin in sensitized animals, respectively. Thus AFL 
(100 mg/kg), more effectively by i.p. than by i.g. route, 
increased the preconvulsive time (PCT) in the guinea-
pigs exposed to an aerosol of histamine to 63.5±5 s 1 h 
after administration compared to 28±1 s in the untreated 
group. However it failed to protect the animals against 
convulsions. These results further suggest that this extract 
has no specific histamine receptor antagonist property. 
To the contrary, in the ovalbumin-induced anaphylactic 
shock in sensitized animals, the extract (100 mg/kg) i.p. 
or i.g. not only prolonged the preconvulsion time but also 
protected the animals against shock during the maximum 
period of 12 min of challenge with allergen. These positive 
results obtained in this model reinforced the promising 
therapeutic potential of the plant observed in previous 
studies (Thomas et al., 1997a). 
 Guinea-pigs are useful as models of immediate 
hypersensitivity to irritants and have pharmacological 
responses similar to humans (Muccitelli et al., 1987), 
although care must be taken when extrapolating this to 
all pathways in the human lung. Other animal models 
use mice, which are easily sensitized to a number of 
antigens, to which they are not normally exposed, 
including ovalbumin (OVA), which is the most popular, 
and a number of recognized human allergens (Zosky et 
al., 2004).
 The preliminary results with C. sympodialis AFL 
on allergy were expanded by a study of the effects of 
AFL oral treatment (p.o.) in ovalbumin-sensitized mice 
showing that the extract (200; 400; 600 mg/kg) inhibited 
both total IgE and OVA-specific IgE production in sera 
from OVA-sensitized mice. The treatment also decreased 
OVA-induced paw edema and increased the production 
of IFN-gamma suggesting AFL may have anti-allergic 
activity through the decrease of IgE production. This 
study was crucial towards the scientific validation of the 
popular use of C. sympodialis for the treatment of asthma 
(Bezerra-Santos et al., 2004).
 Another important mediator of inflammatory 
responses in asthma is the eosinophil. These cells have a 
critical role in the pathogenesis of allergic inflammatory 
conditions, like asthma and at present, the most effective 
pharmacological approach for severe eosinophil-
associated reactions is glucocorticoid therapy (Barnes, 
1995).
 Cissampelos sympodialis AFL as well as its 
isolated alkaloid warifteine were evaluated in two 
models of allergic inflammation (asthma and pleurisy 
models) in actively sensitized mice (Bezerra-Santos et 
al., 2006). Oral pre-treatment with C. sympodialis (4; 
40; 400 mg/kg) was able to inhibit, in a dose-dependent 
manner, both bronchoalveolar lavage (BAL) eosinophil 
and its influx to the pleura caused by allergic challenge 
in actively sensitized animals. A pre-treatment with C. 
sympodialis AFL also inhibited the secretion of cysteinyl 
leukotrienes and the formation of new cytoplasmic 
lipid bodies within recruited eosinophils during allergic 
reaction. The mechanism of C. sympodialis driven 
inhibitory effect does not involve a direct effect on the 
locomotory functions of eosinophils, but the control of the 
production of eosinophilotactic mediators during allergic 
inflammation. Similar effects were observed by pre-
treatment with warifteine (50 μg/animal). This alkaloid 
was able to reduce both eosinophil influx and the pleural 
levels of cysteinyl leukotrienes observed 24 h after allergic 
challenge. Similarly, pre-treatment with warifteine also 
reduced BAL eosinophil influx, production of cysteinyl 
leukotrienes and lipid body formation observed in the 
asthma model. Similarly to the pre-treatment, oral post-
treatment with either C. sympodialis extract or warifteine 
1 h after the last OVA challenge was able to significantly 
inhibit eosinophil influx observed 24 h in both models 
of allergic inflammation. These post-treatments also 
inhibited the production of cysLT caused by allergic 
challenge. Taken together these effects demonstrate 
the potential of C. sympodialis to interfere in the 
pathophysiology of asthma and inflammatory processes 
as well as establishes warifteine as an important bioactive 
marker for C. sympodialis. AFL fraction (Bezerra-Santos 
et al., 2006). Since a phytochemical marker is always 
preferablly the active substance, warifteine is thus 
central for plant identification, quality control, planning 
and monitoring of the technological transformation and 
stability studies (Maciel et al., 2002; Braga et al., 2003; 
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Toledo et al., 2003).
 The mast cell exocytose, after cross-linking 
between allergen and its high affinity IgE receptors, 
delivers an array of inflammatory mediators. The major 
sources of mast cells are the skin, gastrointestinal tract 
and lung, which may explain the clinical symptoms 
of immediate allergic reactions such as dermatitis, 
food allergy and asthma (Galli et al., 2005) .The 
effect of warifteine isolated from C. sympodialis 
was investigated on the allergic response in a murine 
model of asthma, its IgE-dependent mechanisms, 
OVA-specific cell proliferation and NO production in 
peritoneal macrophages. The in vivo treatment with 
warifteine (0.4-10 mg/kg) inhibited OVA-stimulated 
spleen cell proliferative responses and also decreased 
the paw withdrawal latency in both IgE sensitized and 
histamine/5HT-challenged rats. Warifteine was capable 
to downregulate allergen-evoked histamine release 
from isolated peritoneal rat mast cells, suggesting that 
the protective antiallergic effects raised by warifteine 
may result, at least in part, from its ability to stabilize 
mast cells. The antihyperalgesic (4.0 mg/kg) and 
anti-edema effects of warifteine suggest a decrease 
of the inflammatory process by interfering with NO 
production and also in the pre-stored and neo-generated 
mediators. These findings suggest that warifteine may 
represent a new strategy to improve the therapeutic 
arsenal available for controlling immediate allergic 
reactions, like asthma (Costa et al., 2008).
 Cissampelos sympodialis AFL and warifteine 
were also evaluated in an experimental model of 
respiratory allergy to an extract of the dust mite Blomia 
tropicalis (BtE), a model that is considered to resemble 
more closely human asthma than OVA-based models 
(Baqueiro et al., 2010). In the study (Cerqueira-Lima 
et al., 2010) Cissampelos sympodialis AFL (400 mg/
kg/ i.g.) effectively reduced BtE-induced allergy. The 
parameters analyzed were: specific IgE production, cell 
migration and histopathological alterations in the lungs, 
peroxidase (EPO) production in bronchoalveolar lavage 
fluid (BAL) and cytokine production. The treatment of the 
BtE-sensitized mice with AFL decreased the IgE titers, 
although the decrease was not statistically significant. No 
difference was found in macrophages, neutrophils and 
lymphocytes counts among treated and untreated groups 
by the differential cell counts in the BAF, but a significant 
increase in eosinophil numbers was found. The treatment 
also reduced the EPO activity found in the BAL of BtE-
sensitized mice, a fact that may reflect the inhibition 
of eosinophil migration to the lung and promoted a 
significant increase in the production of the regulatory 
cytokine IL-10. The induction of this cytokine could be 
the major effect mediating the anti-allergic activity, by 
modulating cell influx and degranulation. The principal 
function of IL-10 appears to be to limit and ultimately 
terminate inflammatory responses. In addition to these 
activities, IL-10 regulates growth and/or differentiation 
of B cells, NK cells, cytotoxic and helper T cells, mast 
cells, granulocytes, dendritic cells, keratinocytes, and 
endothelial cells. The AFL-induced production of IL-
10 was attributed to the suppression of IL-5 production. 
These activities are correlated to the immunomodulatory 
and anti-inflammatory properties of the isolated alkaloid 
warifteine (tested at 4 mg/kg/ i.g.) but it is probable that 
the effect of warifteine may show an addictive effect 
with other components of the extract to account for 
the potency of the AFL fraction (Cerqueira-Lima et al., 
2010). This hypothesis cannot be definitely ruled out 
because not all C. sympodialis isolated compounds were 
tested and because in general plants usually have analogs 
with similar effects either sharing the same mechanism of 
action or by different mechanisms (Yunes et al., 2001).
 A recent study (Bezerra-Santos et al., 2012b) 
evaluated the effectiveness of C. sympodialis on airway 
hyperreactivity, collagen fibers and mucus production. 
For this purpose, either the standardized hydroalcoholic 
extract of C. sympodialis leaves (0.95% in weight of 
warifteine), as well as warifteine were tested in OVA-
induced lung inflammation in actively sensitized mice. 
The OVA-sensitized and challenged mice pre-treated 
i.g. with either C. sympodialis extract (40 mg/kg) or 
warifteine (2 mg/kg) showed a significant reduction in 
IL-13 levels, comparable to dexamethasone (2 mg/kg) 
treated animals. Similarly to the pre-treatment, oral post-
treatment with warifteine but not with C. sympodialis 
extract was able to inhibit airway hyperreactivity 
in a significant manner. In addition, post-treatment 
with warifteine reduced IL-13 broncoalveolar levels 
detected 6 h after the last OVA challenge in the asthma 
model. These data indicate that C. sympodialis, mostly 
through the active compound warifteine, is capable to 
ameliorate an established inflammatory allergic reaction. 
Oral pre- or post-treatment with C. sympodialis or 
pre-treatment with warifteine reduced OVA-induced 
mucus accumulation and the percentage of mucus 
producing cells to values similar to nonallergic controls. 
Oral pretreatment with C. sympodialis or warifteine 
significantly inhibited OVA-induced eosinophil tissue 
infiltration similar to pre-treatment with dexamethasone. 
This data corroborate the folk anti-allergic medicine use 
of C. sympodialis and indicate that the anti-allergic and 
immunoregulatory properties of C. sympodialis occur 
mostly through the active compound warifteine, to inhibit 
the airway hyperreactivity and lung remodeling through 
a mechanism at least partially dependent of IL-13 and 
eosinophil inhibition (Bezerra-Santos et al., 2012b).
Other pharmacological actions 
 Pharmacological activities other than those 
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directly related to asthma can be attributed to the 
mechanisms previously described for C. sympodialis 
extracts and isolated compounds. These activities 
include antidepressant and CNS stimulant action of C. 
sympodialis extract, possibly related to the inhibition 
of phosphodiesterase activity (Almeida et al., 1998; 
Mendonca-Netto et al., 2008). Cardiovascular effects 
common to phosphodiesterase inhibitors of the 
methylxanthine class (Knight & Yan, 2012) can also 
be observed with C. sympodialis, such as reversible 
hypertension as demonstrated in conscious freely-
moving rats (Medeiros et al., 1998). In addition, the 
immunomodulatory activity of AFL led to the suggestion 
that it can be useful for the treatment of psoriais (Feily 
& Namazi, 2009). Other activities not directly related to 
asthma models reported for C. sympodialis extracts include 
antinociceptive (Oliveira-Junior et al., 2011) action similar 
to the one demonstrated by the hydroalcoholic extract of 
the roots of Cissampelos pareira (Amresh et al., 2007). 
Finally, warifteine has also demonstrated activity against 
promastigotes of Leishmania (L.) chagasi  (Silva et 
al., 2012), thus confi rming the studies demonstrating 
antiparasitic activity against Leishmania sp. (Fournet et 
al., 1993), Trypanosoma cruzi (de Arias et al., 1994) and 
Plasmodium sp. (Angerhofer et al., 1999; Wright et al., 
2000) for bisbenzilisoquinolinic alkaloids.
Conclusion
 The preclinical results reviewed in this paper 
clearly demonstrate the potential of AFL to interfere 
with many important targets related to the asthma 
pathophysiology process. First, there is a direct 
bronchodilator effect which is at least partly mediated by 
warifteine acting on voltage-dependend calcium channels 
and intracellular calcium stores. The anti-infl ammatory 
effect of AFL and warifteine was demonstrated against 
a variety of fl ogistic agents and this effect is mediated 
by its interference with nitric oxide (NO) production 
by macrophages. The immunomodulatory and anti-
allergic effects of AFL and warifteine involve several 
cell types that participate in the asthmatic process. 
These effects include: decrease in neutrophil migration 
and degranulation mediated by phosphodiesterase 
(PDE) inhibition , decrease in eosinophil infi ltration 
into the lungs mediated by inhibition of the production 
of chemoattractant cytokines (e.g. eotaxin), decrease in 
allergen-specifi c immunoglobulin and cell proliferation 
by B lymphocytes, increase of production of anti-
infl ammatory cytokines such as IL-10 and IFN-γ, 
decrease in both mast cell degranulation and histamine 
secretion, decrease in mucus production and the 
Figure 2. Summary of therapeutic targets for Cissampelos sympodialis Eichl. Adapted from (Bezerra-Santos et al., 2012a).
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decrease of cis-leukotriene (CysLTs) and lipid bodies 
accumulation by eosinophiles. Figure 2 summarizes 
the main targets through which the aqueous fraction 
of the ethanol extract of leaves (AFL) of Cissampelos 
sympodialis exerts its effects on asthma. These effects 
show that Cyssampelos sympodialis AFL exert multiple 
and synergistic effects in order to decrease the hallmark 
signs of asthma: bronchospasm, cell migration, mucus 
accumulation, inflammation and airway remodeling. 
Although preclinical results do not warrant clinical 
efficacy, taken together the results clearly point to the 
urgent need to conducted well-controlled clinical trials 
with standardized AFL in humans.
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